Table 2. Comparison of CIBERSORT-selected immune cell fractions between tumor and non-tumor tissues from HCC patients.

Immune cell type	CIBERSORT fraction in % of all infiltrating immune cells (mean ± SD)
	Tumors (n=8)	Non-tumors (n=7)	P value
T cells CD8	0.164±0.066	0.198±0.080	0.422
T cells CD4 naive	0.0±0.0	0.0±0.0	1.0
T cells CD4 memory resting	0.043±0.065	0.058±0.047	0.64
T cells CD4 memory activated	0.005±0.011	0.001±0.002	0.372
T cells follicular helper	0.069±0.033	0.077±0.031	0.675
T cells regulatory (Tregs)	0.052±0.035	0.008±0.009	0.007
T cells gamma delta	0.007±0.011	0.020±0.019	0.152
B cells naive	0.018±0.018	0.023±0.030	0.479
B cells memory	0.017±0.028	0.0±0.001	0.132
Plasma cells	0.069±0.031	0.064±0.028	0.759
NK cells resting	0.005±0.012	0.002±0.004	0.578
NK cells activated	0.042±0.027	0.015±0.019	0.05
Macrophages M0	0.047±0.049	0.0±0.0	0.025
Macrophages M1	0.104±0.029	0.094±0.039	0.605
Macrophages M2	0.126±0.053	0.155±0.050	0.326
Monocytes	0.031±0.028	0.055±0.033	0.184
Dendritic cells resting	0.082±0.065	0.035±0.019	0.09
Dendritic cells activated	0.003±0.006	0.0±0.001	0.31
Mast cells resting	0.0±0.0	0.002±0.004	0.369
Mast cells activated	0.093±0.059	0.154±0.183	0.444
Eosinophils	0.0±0.0	0.0±0.0	1.0
Neutrophils	0.021±0.010	0.032±0.012	0.097

Italic P values indicate significance between individual groups. HCC, hepatocellular carcinoma.